Digital healthcare platform company Lemon Healthcare has finalized its public offering price at 10,000 won and is set to list on the KOSDAQ market on July 6. During institutional bookbuilding, the company recorded a competition ratio of 1,238 to 1, drawing significant market attention. As of the morning of the 25th, the second day of the subscription period, Lemon Healthcare's equal allocation ratio stands at approximately 2.05.

■ Bidirectional Medical MyData Relay via Core Technology 'LDB'

Lemon Healthcare is a digital healthcare platform company that connects hospitals, patients, insurance companies, pharmaceutical companies, pharmacies, financial institutions, and healthcare enterprises based on its medical MyData platform technology. The company's core technology is 'LDB (Lemon Digital Bridge),' a bidirectional medical MyData relay platform that collects patient medical data generated at hospitals in real time, then converts and provides it according to the needs of utilizing institutions. The company operates its business through three platforms: ▲ LDB-H, a platform that builds smart hospital services for patients and medical staff; ▲ LDB-E, a platform that securely relays medical data to external demand institutions such as insurance companies, pharmacies, pharmaceutical companies, financial institutions, and healthcare enterprises; and ▲ LDB-D, a platform that provides refined, analyzed, and processed health data in API format to support the development of personalized health management services and AI-based health data analysis services.

■ "Differentiated from B2C-Centric Commerce Models"… Aiming to Become a Global Medical Data Company

Lemon Healthcare possesses platform technology that collects and standardizes patients' medical data in real time, then converts and provides it to meet the needs of various institutions. This is evaluated as a competitive advantage that differentiates the company from typical digital healthcare firms that operate B2C-centric commerce business models based on reservation fees. Going forward, the company aims to build a digital healthcare ecosystem that comprehensively manages individuals' medical data across life stages from birth to old age, in line with the expansion of the medical MyData market, enabling various participants—including hospitals, patients, and enterprises—to utilize the data. Based on this, the company's strategy is to grow into a globally competitive medical data service company.

The market expects that if the activation of the medical MyData system and the growth of the AI-based digital healthcare industry continue, interest will likely grow in the expansion potential of Lemon Healthcare's platform business.

[This article was generated with the assistance of AI. This article is intended to provide general corporate information and does not constitute a recommendation to invest in any specific stock. The final decision and responsibility for investments lie with the investor.]